Intelligent Living (NASDAQ:ILAG) Stock, Quote.Headers.trade-ideas

Intelligent Living

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

ATXG

BLDP

CNET

CTNT

GLPG

GSX Techedu Inc. American Depositary Shares

GOTU

ILAG

MAPS

SMFL

SOPA

TANH

TCOM

TRIB

TUYA

VVPR

Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

analysis-4937349

BLND

BSGM

CHGG

COUR

CSLR

CYCC

GWAV

ICLK

LICN

LOGI

MOVE

MRIN

SGBX

WRNT

ZAPP

Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket

Caterpillar - logo

ACON

AIRE

ATNI

BMRN

BNAI

BPTS

BRFH

BRKL

CDTX

CSSE

ESGL

FCFS

HRYU

HUIZ

JAKK

OPTN

ORGO

PCSA

POAI

PTSI

SNBR

SPCB

STRA

ULBI

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Intelligent Living Application Group Inc. - Ordinary Shares

Intelligent Living Application Group Inc

Wedbush analyst Nick Setyan reiterates Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) with a Outperform and maintains $190 price target.

Price Target

Reiteration

Analyst Ratings

TXRH

Wedbush Reiterates Outperform on Texas Roadhouse, Maintains $190 Price Target

Canadian game developer SkyBox Labs has laid off 25 employees, becoming the latest studio affected by the sweeping economic difficulties plaguing the <a href="https://www.benzinga.com/general/gaming">gaming industry. </a>
In a statement <a href="https://www.linkedin.com/posts/skyboxlabs_today-we-informed-our-studio-that-we-made-activity-7242279185761607680-Xesv/">shared</a> on LinkedIn last week, SkyBox said: &#8220;Today we informed our studio that we made a reduction to our staff at SkyBox.&#8221;
&#8220;In total, 25 people from our studio have been affected. Despite all our best efforts, we are not immune to the unprecedented challenges that have impacted so many companies in the industry.&#8221;
See Also: <a href="https://www.benzinga.com/markets/asia/24/08/40659768/netease-to-close-ouka-studios-developer-of-visions-of-mana-report">NetEase To Close Ouka Studios, Developer Of Visions Of Mana: Report</a>
SkyBox Labs has contributed to significant co-development projects. Halo Infinite, Minecraft, and Fallout 76 are among the titles it developed. The recent layoffs come less than two years after Chinese gaming giant NetEase Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) acquired the studio. 
Despite the backing of a major publisher, SkyBox's struggles reflect a broader trend in the industry. Nowadays, developers face a combination of rising production costs, increased competition, and evolving market demands.
&#8220;Every impacted employee will be fully supported through severance, extended benefits, career transition services, and connection to other resources to provide them with the assistance they require during this difficult time,&#8221; the company promised. 
<h3 class="wp-block-heading">Industry-Wide Pressures</h3>
Numerous studios, both large and small, have been forced to adjust. The post-pandemic environment is marked by rising costs and shifting consumer expectations. 
Game development timelines have become longer, production budgets have skyrocketed, and monetization strategies have come under intense scrutiny. 
SkyBox and other studios specializing in co-development must maintain profitability while navigating the demands of larger publishers. This adds yet another layer of complexity.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40502799/netease-q2-revenue-falls-short-gaming-segment-shines">NetEase Q2: Revenue Falls Short, Gaming Segment Shines</a></li>
</ul>
Image credits: Shutterstock.

Gaming

General

NTES

NetEase-Owned SkyBox Labs Slashes Workforce Due To 'Unprecedented Challenges'

MSFT

Microsoft To Invest $1.3B Over Next Three Years To Empower Mexico With Cloud And AI

Piper Sandler analyst Kashy Harrison maintains Generac Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) with a Overweight and maintains $175 price target.

GNRC

Piper Sandler Maintains Overweight on Generac Hldgs, Maintains $175 Price Target

Monness, Crespi, Hardt analyst Gus Gala reiterates Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Neutral.

Monness, Crespi, Hardt Reiterates Neutral on Visa

Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares continue to slide Tuesday despite corporate updates <a href="https://www.benzinga.com/pressreleases/24/09/g41002804/mullen-ceo-provides-video-update-to-shareholders">from CEO David Michery.&nbsp;</a>
The Details:
Michery is featured in a video released Tuesday morning in which he states the company was compelled to do another reverse split to work towards regaining compliance with Nasdaq&#8217;s minimum bid price rule, and the current stock price does not represent the value of Mullen.
Read Next: <a href="https://www.benzinga.com/news/24/09/40991747/snowflake-stock-dips-on-offering-after-hours-what-to-know">Snowflake Stock Dips On Offering After-Hours: What To Know</a>
"Our group of companies, including Bollinger Motors and Mullen Advanced Energy Operations, continue to work towards meeting milestones and growing sales and I remain optimistic that the Company&#8217;s success will continue despite the challenges associated with our stock price,&#8221; said Michery.&nbsp;
Mullen effected a 1-for-100<a href="https://www.benzinga.com/news/24/09/40859068/whats-going-on-with-mullen-automotive-shares-friday?_gl=1&#x2A;1wt4ghp&#x2A;_gcl_au&#x2A;MjA0MjY5MDc2MS4xNzI3MDk3MDI4&#x2A;_ga&#x2A;MTI0NDgzMzI1OS4xNzI3MDk3MDI4&#x2A;_ga_V7ZK73W7N0&#x2A;MTcyNzExOTc2OS4yLjEuMTcyNzE5NDU0Mi4wLjAuMA.."> reverse stock split</a> on Sept. 17, and Mullen's stock is down nearly 50% since then. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Mullen shares are moving lower on heavy trading volume Tuesday with nearly 900,000 shares already traded in the session.&nbsp;
<h3 class="wp-block-heading">How To Buy MULN Stock: </h3>
By now you're likely curious about how to participate in the market for Mullen Automotive &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of Mullen Automotive, which is trading at $5.99 as of publishing time, $100 would buy you 16.69 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
MULN Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Mullen Automotive shares are down 110.2% at $5.26 at the time of publication Tuesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40991529/what-happened-with-palantir-stock-today">What Happened With Palantir Stock Today?</a></li>
</ul>
Image: Courtesy of Mullen Automotive, Inc.

MULN

What's Going On With EV-Maker Mullen Automotive's Stock?

Ratings for Pacific Premier Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBI#NASDAQ">PPBI</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Pacific Premier Bancorp, presenting an average target of $26.5, a high estimate of $28.00, and a low estimate of $25.00. Observing a 4.95% increase, the current average has risen from the previous average price target of $25.25. 
<img src="https://www.benzinga.com/files/images/story/2024/1727200870_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Pacific Premier Bancorp among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$27.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Feaster</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Pacific Premier Bancorp. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Pacific Premier Bancorp compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Pacific Premier Bancorp's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Pacific Premier Bancorp's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PPBI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Pacific Premier Bancorp analyst ratings.</a>
<h2>Unveiling the Story Behind Pacific Premier Bancorp</h2>
Pacific Premier Bancorp Inc through its subsidiaries, provides banking products and services. It offers cash management, electronic banking services, credit facilities, and retirement accounts, among others.
<h3>Key Indicators: Pacific Premier Bancorp's Financial Health</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Challenges: Pacific Premier Bancorp's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -17.2%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 29.06%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Pacific Premier Bancorp's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.41%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.22%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.18.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PPBI

Beyond The Numbers: 4 Analysts Discuss Pacific Premier Bancorp Stock

13 analysts have shared their evaluations of Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Braze and provided 12-month price targets. The average target is $61.15, accompanied by a high estimate of $75.00 and a low estimate of $45.00. This current average represents a 3.88% decrease from the previous average price target of $63.62. 
<img src="https://www.benzinga.com/files/images/story/2024/1727200858_0_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Braze among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>J. Derrick Wood</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Yun Kim</td>
<td>Loop Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Brian Schwartz</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$51.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$65.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Ryan Macwilliams</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Nick Altmann</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$56.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Braze. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Braze compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Braze's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Braze's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BRZE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Braze analyst ratings.</a>
<h2>Get to Know Braze Better</h2>
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail &amp; E-commerce, Media &amp; Entertainment, Financial Services, and Travel &amp; Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates a majority of its revenue from the United States.
<h3>Breaking Down Braze's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Braze displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately 26.4%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Braze's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -15.81%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Braze's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -5.17%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Braze's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -2.8%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Braze's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.19.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BRZE

Deep Dive Into Braze Stock: Analyst Perspectives (13 Ratings)

Deep-pocketed investors have adopted a bearish approach towards UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in UNH usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 24 extraordinary options activities for UnitedHealth Group. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 20% leaning bullish and 66% bearish. Among these notable options, 17 are puts, totaling $927,651, and 7 are calls, amounting to $479,810.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $300.0 to $660.0 for UnitedHealth Group during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of UnitedHealth Group stands at 133.33, with a total volume reaching 2,271.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in UnitedHealth Group, situated within the strike price corridor from $300.0 to $660.0, throughout the last 30 days.
<h3>UnitedHealth Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727200858_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.9</td>
<td>$2.89</td>
<td>$2.9</td>
<td>$620.00</td>
<td>$218.3K</td>
<td style="text-align: right;">673</td>
<td style="text-align: right;">736</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$165.15</td>
<td>$162.9</td>
<td>$162.9</td>
<td>$430.00</td>
<td>$81.4K</td>
<td style="text-align: right;">32</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$31.35</td>
<td>$29.75</td>
<td>$30.06</td>
<td>$580.00</td>
<td>$74.9K</td>
<td style="text-align: right;">349</td>
<td style="text-align: right;">150</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$30.15</td>
<td>$29.7</td>
<td>$29.89</td>
<td>$580.00</td>
<td>$74.5K</td>
<td style="text-align: right;">349</td>
<td style="text-align: right;">125</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$29.65</td>
<td>$28.9</td>
<td>$29.27</td>
<td>$580.00</td>
<td>$67.1K</td>
<td style="text-align: right;">349</td>
<td style="text-align: right;">221</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Having examined the options trading patterns of UnitedHealth Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of UnitedHealth Group</h3>
<ul>
<li>Trading volume stands at 1,384,480, with UNH's price down by -0.14%, positioned at $572.63.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 21 days.</li>
</ul>
<h3>What Analysts Are Saying About UnitedHealth Group</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $591.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $591. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $591. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $591. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest UnitedHealth Group options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Spotlight on UnitedHealth Group: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 16 uncommon options trades for Amgen.
This isn't normal.
The overall sentiment of these big-money traders is split between 43% bullish and 43%, bearish.
Out of all of the special options we uncovered, 10 are puts, for a total amount of $1,298,955, and 6 are calls, for a total amount of $312,382.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $145.0 to $390.0 for Amgen over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Amgen stands at 388.45, with a total volume reaching 3,084.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Amgen, situated within the strike price corridor from $145.0 to $390.0, throughout the last 30 days.
<h3>Amgen Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727200853_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$20.5</td>
<td>$19.95</td>
<td>$20.03</td>
<td>$330.00</td>
<td>$801.2K</td>
<td style="text-align: right;">590</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$20.15</td>
<td>$20.0</td>
<td>$20.05</td>
<td>$330.00</td>
<td>$188.3K</td>
<td style="text-align: right;">590</td>
<td style="text-align: right;">538</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$190.8</td>
<td>$186.9</td>
<td>$188.7</td>
<td>$145.00</td>
<td>$132.0K</td>
<td style="text-align: right;">40</td>
<td style="text-align: right;">7</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$7.85</td>
<td>$6.85</td>
<td>$7.3</td>
<td>$360.00</td>
<td>$70.0K</td>
<td style="text-align: right;">109</td>
<td style="text-align: right;">96</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$4.1</td>
<td>$3.8</td>
<td>$4.1</td>
<td>$335.00</td>
<td>$52.4K</td>
<td style="text-align: right;">235</td>
<td style="text-align: right;">265</td>
</tr>
</tbody>
</table>

<h3>About Amgen</h3>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
<h3>Present Market Standing of Amgen</h3>
<ul>
<li>With a trading volume of 737,520, the price of AMGN is down by -0.96%, reaching $332.39.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 35 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

AMGN

Market Whales and Their Recent Bets on AMGN Options

5 analysts have expressed a variety of opinions on Cibus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBUS#NASDAQ">CBUS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Cibus, revealing an average target of $22.3, a high estimate of $25.00, and a low estimate of $20.00. This current average represents a 1.63% decrease from the previous average price target of $22.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1727200849_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Cibus among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Venezia</td>
<td>Alliance Global Partners</td>
<td>Lowers</td>
<td>Buy</td>
<td>$23.50</td>
<td>$25.00</td>
</tr>
<tr>
<td>Austin Moeller</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Austin Moeller</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$21.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Matthew Venezia</td>
<td>Alliance Global Partners</td>
<td>Announces</td>
<td>Buy</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Austin Moeller</td>
<td>Canaccord Genuity</td>
<td>Announces</td>
<td>Buy</td>
<td>$22.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cibus. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Cibus compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Cibus's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Cibus's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CBUS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cibus analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Cibus's Background</h2>
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
<h3>Cibus's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Positive Revenue Trend: Examining Cibus's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 325.38% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Cibus's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -3398.33%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Cibus's ROE stands out, surpassing industry averages. With an impressive ROE of -10.38%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -5.24%, the company showcases effective utilization of assets.
Debt Management: Cibus's debt-to-equity ratio is below the industry average. With a ratio of 0.14, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CBUS

Unveiling 5 Analyst Insights On Cibus

Investors with a lot of money to spend have taken a bearish stance on Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with APO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Apollo Global Management.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 55%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $114,190, and 7 are calls, for a total amount of $2,226,510.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $77.5 to $140.0 for Apollo Global Management over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Apollo Global Management's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Apollo Global Management's significant trades, within a strike price range of $77.5 to $140.0, over the past month.
<h3>Apollo Global Management Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727200848_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>APO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.9</td>
<td>$5.5</td>
<td>$5.8</td>
<td>$140.00</td>
<td>$1.1M</td>
<td>1.1K</td>
<td>3.5K</td>
</tr>
<tr>
<td>APO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.9</td>
<td>$5.6</td>
<td>$5.8</td>
<td>$140.00</td>
<td>$870.0K</td>
<td>1.1K</td>
<td>1.5K</td>
</tr>
<tr>
<td>APO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.8</td>
<td>$5.5</td>
<td>$5.8</td>
<td>$140.00</td>
<td>$81.2K</td>
<td>1.1K</td>
<td>2.1K</td>
</tr>
<tr>
<td>APO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.25</td>
<td>$2.15</td>
<td>$2.25</td>
<td>$122.00</td>
<td>$74.4K</td>
<td>0</td>
<td>331</td>
</tr>
<tr>
<td>APO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.35</td>
<td>$2.15</td>
<td>$2.35</td>
<td>$122.00</td>
<td>$39.7K</td>
<td>0</td>
<td>500</td>
</tr>
</tbody>
</table>

<h3>About Apollo Global Management</h3>
Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Asset Management, Retirement Services, and Principal Investing. It generates maximum revenue from the Retirement Services segment.
Following our analysis of the options activities associated with Apollo Global Management, we pivot to a closer look at the company's own performance.
<h3>Where Is Apollo Global Management Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,772,666, with APO's price down by -0.14%, positioned at $125.06.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 36 days.</li>
</ul>
<h3>Professional Analyst Ratings for Apollo Global Management</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $142.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Wells Fargo lowers its rating to Overweight with a new price target of $132. 
&#x2A; An analyst from Redburn Atlantic has revised its rating downward to Buy, adjusting the price target to $153. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Apollo Global Management options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Behind the Scenes of Apollo Global Management's Latest Options Trends

In the latest quarter, 7 analysts provided ratings for SLM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $27.14, a high estimate of $29.00, and a low estimate of $25.00. Marking an increase of 7.96%, the current average surpasses the previous average price target of $25.14. 
<img src="https://www.benzinga.com/files/images/story/2024/1727200842_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of SLM among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Michael Kaye</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$27.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Mark Devries</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$29.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$27.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$29.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to SLM. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of SLM compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of SLM's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of SLM's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SLM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on SLM analyst ratings.</a>
<h2>All You Need to Know About SLM</h2>
SLM Corp is the largest student lender in the country. It makes and holds student loans through the guaranteed Federal Family Education Loan Program as well as through private channels. It also engages in debt-management operations, including accounts receivable and collections services, and runs college savings programs.
<h3>Breaking Down SLM's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: SLM's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -3.15%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: SLM's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 48.13%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): SLM's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 12.7%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): SLM's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.87% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.66, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying SLM: Insights From 7 Analyst Reviews

In the last three months, 4 analysts have published ratings on CVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVBF#NASDAQ">CVBF</a>), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for CVB Financial, presenting an average target of $20.5, a high estimate of $21.00, and a low estimate of $20.00. This upward trend is apparent, with the current average reflecting a 6.49% increase from the previous average price target of $19.25.
<img src="https://www.benzinga.com/files/images/story/2024/1727200828_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive CVB Financial is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Kelly Motta</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CVB Financial. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CVB Financial compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of CVB Financial's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CVBF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CVB Financial analyst ratings.</a>
<h2>Delving into CVB Financial's Background</h2>
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.
<h3>Financial Insights: CVB Financial</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: CVB Financial's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -5.24%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: CVB Financial's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 39.7% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): CVB Financial's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.37% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): CVB Financial's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.3%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.24.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVBF

Where CVB Financial Stands With Analysts

Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) has outperformed the market over the past 5 years by 18.39% on an annualized basis producing an average annual return of 32.37%. Currently, Moderna has a market capitalization of $24.87 billion. 
Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 5 years ago, it would be worth $406.92 today based on a price of $64.70 for MRNA at the time of writing.
<h3>Moderna's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727200826_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MRNA

Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today

Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) has outperformed the market over the past 5 years by 30.63% on an annualized basis producing an average annual return of 44.6%. Currently, Broadcom has a market capitalization of $812.52 billion. 
Buying $100 In AVGO: If an investor had bought $100 of AVGO stock 5 years ago, it would be worth $636.73 today based on a price of $174.55 for AVGO at the time of writing.
<h3>Broadcom's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727200821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVGO

If You Invested $100 In This Stock 5 Years Ago, You Would Have $600 Today

In the latest quarter, 13 analysts provided ratings for Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $89.23, a high estimate of $105.00, and a low estimate of $74.00. Witnessing a positive shift, the current average has risen by 15.42% from the previous average price target of $77.31.
<img src="https://www.benzinga.com/files/images/story/2024/1727200809_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Western Alliance by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Steven Alexopoulos</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Bernard von-Gizycki</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$83.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Ebrahim Poonawala</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$98.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$88.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$87.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$85.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Matthew Clark</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$93.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$78.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$74.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Casey Haire</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$77.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Western Alliance. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Western Alliance compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Western Alliance's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Western Alliance's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WAL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Western Alliance analyst ratings.</a>
<h2>Unveiling the Story Behind Western Alliance</h2>
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking. Corporate &amp; Other.
<h3>Western Alliance: Financial Performance Dissected</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Western Alliance displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 4.53%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 32.6%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Western Alliance's ROE stands out, surpassing industry averages. With an impressive ROE of 3.2%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Western Alliance's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.24%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.1, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Western Alliance: Insights From 13 Analyst Reviews

Raymond James analyst Frank Louthan maintains Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) with a Outperform and raises the price target from $44 to $48.

Raymond James Maintains Outperform on Verizon Communications, Raises Price Target to $48

CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">marginally lower on Tuesday.</a>
Jefferies analyst Joseph Gallo maintained the Buy rating on the stock, raising the price forecast from&nbsp;$315&nbsp;to&nbsp;$345.
Today, Adam Meyers, a senior executive at CrowdStrike is set to testify before the U.S. Congress regarding the global IT outage that occurred on July 19.
Meyers is expected to express deep regret about the incident and emphasize his company&#8217;s commitment to preventing a recurrence, <a target="_blank" href="https://www.bbc.com/news/articles/cr54m92ermgo" rel="noreferrer noopener">reported </a>BBC.
The incident, caused by a software update, left stranded travelers and small businesses facing significant sales losses. The update affected millions of computers running Microsoft systems worldwide.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39873706/crowdstrike-outage-impacted-less-than-1-of-windows-devices-but-still-managed-to-wreak-havoc-report" rel="noreferrer noopener">CrowdStrike Outage Impacted Less Than 1% Of Windows Devices But Still Managed To Wreak Havoc: Report</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, CRWD stock has gained over 81% in the past year. Investors can gain exposure to the stock via&nbsp;REX AI Equity Premium Income ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIPI#NASDAQ">AIPI</a>).
In a blog&nbsp;<a target="_blank" href="https://blogs.microsoft.com/blog/2024/07/20/helping-our-customers-through-the-crowdstrike-outage/" rel="noreferrer noopener">post</a> in July, Microsoft highlighted the widespread impact of the outage, attributing it to the extensive use of CrowdStrike by businesses running critical services.
&#8220;This incident demonstrates the interconnected nature of our broad ecosystem — global cloud providers, software platforms, security vendors and other software vendors, and customers,&#8221; Microsoft shared in the post.
&#8220;It&#8217;s also a reminder of how important it is for all of us across the tech ecosystem to prioritize operating with safe deployment and disaster recovery using the mechanisms that exist.&#8221;
Related: <a target="_blank" href="https://www.benzinga.com//node/40657754" rel="noreferrer noopener">CrowdStrike Stock Nears Death Cross As Delta Dispute Escalates</a>
Security researcher Troy Hunt had <a target="_blank" href="https://x.com/troyhunt/status/1814198760387596407" rel="noreferrer noopener">described </a>it as the &#8220;largest IT outage in history,&#8221; especially since tech companies managed <a target="_blank" href="https://www.benzinga.com/news/24/07/39870313/microsoft-crowdstrike-issue-caused-largest-it-outage-in-history-showing-how-much-we-depend-on-a-hand" rel="noreferrer noopener">to avoid the &#8220;Y2K&#8221; issue.</a>
Recently, CrowdStrike revised its revenue and <a href="https://www.benzinga.com//node/40620121" target="_blank" rel="noreferrer noopener">profit projections downward.</a>
Price Action: CRWD shares are trading lower by 1.09% to $289.94 at last check Tuesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/09/41008403/consumer-confidence-tumbles-as-concerns-over-labor-market-grow-odds-rise-for-50-b" target="_blank" rel="noreferrer noopener">Consumer Confidence Tumbles As Concerns Over Labor Market Grow, Odds Rise For 50-Basis-Point Interest Rate Cut In November</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Media

AIPI

CRWD

What's Going On With CrowdStrike Stock Today?

Raymond James analyst Wilma Burdis maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Strong Buy and raises the price target from $228 to $250.

Raymond James Maintains Strong Buy on Reinsurance Gr, Raises Price Target to $250

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning!



Moving stocks this morning are earnings reports, clinical trial data, a delisting notice and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Intelligent Living (NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) stock is rocketing more than 78% alongside heavy pre-market trading.</li>



<li>ReAlpha Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/aire-stock-quote/">AIRE</a>) shares are soaring over 28% after launching an <a href="https://www.nasdaq.com/press-release/realpha-tech-corp.-launches-claire-real-estates-first-ai-powered-zero-commission">artificial intelligence (AI) real estate buyer&rsquo;s agent</a>.</li>



<li>Cidara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdtx-stock-quote/">CDTX</a>) stock is surging more than 22% after <a href="https://finance.yahoo.com/news/cidara-therapeutics-reacquires-global-development-200500299.html">reacquiring a flu treatment</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) shares are rising over 19% with strong early morning trading.</li>



<li>Nutex Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/nutx-stock-quote/">NUTX</a>) stock is increasing close to 18% alongside heavy trading this morning.</li>



<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) shares are gaining 17% on strong trading today.</li>



<li>Acrivon Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/acrv-stock-quote/">ACRV</a>) stock is climbing more than 13% on <a href="https://www.nasdaq.com/press-release/acrivon-therapeutics-reports-initial-positive-clinical-data-for-acr-368-and-pipeline">positive clinical trial data</a>.</li>



<li>HWH International (NASDAQ:<a href="https://investorplace.com/stock-quotes/hwh-stock-quote/">HWH</a>) shares are getting an over 13% boost with no clear news this morning.</li>



<li>Cia Energetica DE Minas (NYSE:<a href="https://investorplace.com/stock-quotes/cig-stock-quote/">CIG</a>) stock is jumping more than 12% on Thursday.</li>



<li>Alpha Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/atgl-stock-quote/">ATGL</a>) shares are up over 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>GraniteShares 2x Long META Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/fbl-stock-quote/">FBL</a>) stock is diving more than 28% as Meta Platforms stock falls with its <a href="https://finance.yahoo.com/video/meta-stock-falls-disappointing-q2-202013597.html">latest earnings report</a>.</li>



<li>Chicken Soup for the Soul (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) shares are retreating over 25% <a href="https://finance.yahoo.com/news/chicken-soup-soul-entertainment-receives-210500427.html">following a delisting warning</a>.</li>



<li>Biophytis (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpts-stock-quote/">BPTS</a>) stock is tumbling more than 24% after announcing a <a href="https://www.nasdaq.com/press-release/biophytis-announces-transfer-of-adss-to-otc-market-2024-04-24">transfer to the OTC Market</a>.</li>



<li>Barfresh Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/brfh-stock-quote/">BRFH</a>) shares are taking an over 15% beating this morning.</li>



<li>ESGL (NASDAQ:<a href="https://investorplace.com/stock-quotes/esgl-stock-quote/">ESGL</a>) stock is dropping more than 14% today.</li>



<li>Meta Platforms (NASDAQ:<a href="https://investorplace.com/stock-quotes/meta-stock-quote/">META</a>) shares are sliding nearly 14% with <a href="https://finance.yahoo.com/video/meta-stock-falls-disappointing-q2-202013597.html">its earnings release</a>.</li>



<li>Tidal ETF Trust II YieldMax META Option Income Strategy ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/fby-stock-quote/">FBY</a>) stock is decreasing 13% alongside META shares.</li>



<li>Society Pass (NASDAQ:<a href="https://investorplace.com/stock-quotes/sopa-stock-quote/">SOPA</a>) shares are slipping over 12% on Thursday.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is dipping more than 12% this morning.</li>



<li>AGBA Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) shares close out our pre-market stock movers down over 11% <a href="https://www.mmafighting.com/2024/4/22/24137378/bkfc-owners-at-triller-acquired-by-hong-kong-based-finance-company-in-4-billion-merger">following a recent merger</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-25th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Intelligent Living&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) stock is rocketing higher on Thursday despite a lack of news from the mechanical locksets manufacturing company.



There are no press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is up today. No analyst coverage is pushing the shares higher, either.



What is happening with ILAG stock today is heavy trading of its shares. That has more than 7 million shares of the company&rsquo;s stock changing hands during pre-market trading today. This is well above its daily average trading volume of about 575,000 shares.



Investors will also note that ILAG is a penny stock. This comes from its prior closing price of 54 cents and its market capitalization of just $9.752 million.



<h2>What This Means for ILAG Stock</h2>



Being a penny stock means ILAG shares are more susceptible to manipulation and volatility. That might explain why the shares are rising with heavy trading today and no news.



Another thing to keep in mind about Intelligent Living is its low trading price. Being under $1 per share puts it in danger of being delisted. The company <a href="https://www.nasdaq.com/press-release/intelligent-living-application-group-inc.-granted-extension-to-meet-nasdaq-minimum">just got an extension</a> from the Nadaq Exchange last week that gives until until Oct. 14, 2024 to fix this issue.



ILAG stock is up 56.3% as of Thursday morning. The shares were down 25% year-to-date when markets closed yesterday.



Investors will find more of the most recent stock market stories ready to go below!



We have all of the hottest stock market news worth reading about on Thursday! That includes the biggest pre-market stock movers this morning, the latest news for electric vehicle (EV) stock and more. All of that info is available at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-25th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li><a href="https://investorplace.com/2024/04/3-ev-stocks-to-buy-asap-before-demand-ramps-right-back-up/">3 EV Stocks to Buy ASAP Before Demand Ramps Right Back Up</a></li>



<li><a href="https://investorplace.com/2024/04/ground-beef-recalls-what-to-know-about-nationwide-recalls-due-to-e-coli/">Ground Beef Recalls: What to Know About Nationwide Recalls Due to E. Coli</a></li>
</ul>On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-intelligent-living-ilag-stock-up-56-today/">Why Is Intelligent Living (ILAG) Stock Up 56% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Intelligent Living (ILAG) Stock Up 56% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
ReAlpha Tech&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/aire-stock-quote/">AIRE</a>) stock continues to rally on Thursday <a href="https://www.nasdaq.com/press-release/realpha-tech-corp.-launches-claire-real-estates-first-ai-powered-zero-commission">following the launch</a> of its first artificial intelligence (<a href="https://investorplace.com/stock-quotes/ai-stock-quote/">AI</a>) real estate Smart Buyer&rsquo;s Agent.



Claire is the name of this new service and it comes with zero commission. The AI service from the company guides buyers through the home buying process without the need for a real estate agent.



Claire is currently limited in its scope with it only being available to buyers in Palm Beach,&nbsp;Miami-Dade and&nbsp;Broward&nbsp;Counties in Florida. The company hopes to expand the service to reach a larger customer base.



Mike Logozzo, president and Chief Operating Officer of ReAlpha Tech, said the following about the launch.




&ldquo;Our goal when creating Claire was simple: to completely reinvent the homebuying process through the use of AI to help homebuyers find their dream home, at a great price, with the best experience.&rdquo;




<h2>AIRE Stock Movement</h2>



AIRE stock is seeing heavy trading on Thursday following the AI real estate buyer assistant&rsquo;s launch. This has more than 9 million shares traded as of this writing. That&rsquo;s well above its daily average trading volume of about 1.7 million shares.



AIRE stock is up 43% as of Thursday morning. That builds on its 93% rally when markets closed yesterday.



Investors will find more of the most recent stock market news today below!



We have all of the hottest stock market stories for Thursday! Among that is what has shares of Intelligent Living&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) stock up, the biggest pre-market stock movers this morning and more. All of this news is available at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-intelligent-living-ilag-stock-up-56-today/">Why Is Intelligent Living (ILAG) Stock Up 56% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-25th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li><a href="https://investorplace.com/2024/04/3-ev-stocks-to-buy-asap-before-demand-ramps-right-back-up/">3 EV Stocks to Buy ASAP Before Demand Ramps Right Back Up</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-realpha-tech-aire-stock-up-43-today/">Why Is ReAlpha Tech (AIRE) Stock Up 43% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is ReAlpha Tech (AIRE) Stock Up 43% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
GraniteShares 2x Long META Daily ETF&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/fbl-stock-quote/">FBL</a>) stock is taking a beating on Thursday after Meta Platforms (NASDAQ:<a href="https://investorplace.com/stock-quotes/meta-stock-quote/">META</a>) released its <a href="https://finance.yahoo.com/video/meta-stock-falls-disappointing-q2-202013597.html">latest earnings report</a>.



The bad news from the earnings report concerns Meta Platforms&rsquo; outlook for the second quarter of 2024. It&rsquo;s expecting revenue for the period to range from $36.5 billion to $39 billion. The $37.75 billion midpoint of that guidance is below Wall Street&rsquo;s estimate of $38.24 billion.



That&rsquo;s despite the company posting positive results for its first quarter of 2024. Its adjusted EPS and revenue of $4.71 and $36.46 billion both beat analysts&rsquo; estimates of $4.30 per share and $36.12 billion.



<h2>What This Means for FBL Stock</h2>



GraniteShares 2x Long META Daily ETF&nbsp;is an exchange-traded fund that tracks META stock. That means movement from the social media giant&rsquo;s shares are reflected in FBL&rsquo;s stock price. The ETF seeks investment results that are two times the daily percentage change of META shares.



All of this has FBL stock seeing a fair amount of trading today alongside the Meta Platforms earnings report. That has more than 362,000 shares changing hands as of this writing. That&rsquo;s closing in on the ETF&rsquo;s daily average trading volume of about 457,000 shares.



FBL stock is down 30.5% while META stock is down 15.1% as of Thursday morning.



Investors will find even more of the most recent stock market stories below!



We have all of the hottest stock market news traders need to know about on Thursday! A few examples include what&rsquo;s happening with shares of ReAlpha Tech&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/aire-stock-quote/">AIRE</a>) and Intelligent Living&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) stock as well as the biggest movers this morning. You can catch up on all of this news below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-realpha-tech-aire-stock-up-43-today/">Why Is ReAlpha Tech (AIRE) Stock Up 43% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-intelligent-living-ilag-stock-up-56-today/">Why Is Intelligent Living (ILAG) Stock Up 56% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-25th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-graniteshares-2x-long-meta-daily-etf-fbl-stock-down-31-today/">Why Is GraniteShares 2x Long META Daily ETF (FBL) Stock Down 31% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is GraniteShares 2x Long META Daily ETF (FBL) Stock Down 31% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!



Moving stocks this morning are earnings reports, a proposed public offering update and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Cyclacel Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cycc-stock-quote/">CYCC</a>) stock is rocketing more than 88% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318272879&amp;type=PDF&amp;symbol=CYCC&amp;cdn=7ad97fd60a2342c353526cb159fb854c&amp;companyName=Cyclacel+Pharmaceuticals+Inc.&amp;formType=RW&amp;formDescription=Registration+Withdrawal+Request&amp;dateFiled=2024-04-29">withdrawing a proposed public offering</a>.</li>



<li>Greenwave Technology Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/gwav-stock-quote/">GWAV</a>) shares are soaring over 29% on heavy pre-market trading.</li>



<li>Marin Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrin-stock-quote/">MRIN</a>) stock is surging close to 25% after launching an <a href="https://www.nasdaq.com/press-release/marin-software-launches-ai-powered-anomaly-detector-to-unlock-growth-in-performance">artificial intelligence (AI)-powered anomaly detector</a>.</li>



<li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) shares are rising more than 22% without any clear news this morning.</li>



<li>Sensata Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/st-stock-quote/">ST</a>) stock is gaining over 20% after <a href="https://www.msn.com/en-us/money/markets/st-stock-earnings-sensata-technologies-beats-eps-beats-revenue-for-q1-2024/ar-AA1nTpkv?ocid=finance-verthp-feeds">beating EPS and revenue estimates</a> in Q1.</li>



<li>GeneDx (NASDAQ:<a href="https://investorplace.com/stock-quotes/wgs-stock-quote/">WGS</a>) shares are increasing 20% after <a href="https://www.nasdaq.com/articles/genedx-holdings-corp.-wgs-reports-q1-loss-tops-revenue-estimates">Q1 revenue beat estimates</a>.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) stock is climbing more than 19% despite a lack of news today.</li>



<li>Blend Labs (NYSE:<a href="https://investorplace.com/stock-quotes/blnd-stock-quote/">BLND</a>) shares are heading over 19% higher on <a href="https://www.businesswire.com/news/home/20240429786929/en/Blend-Labs-Announces-Strategic-Partnership-with-Haveli-Investments-including-150-Million-Investment">a strategic partnership</a>.</li>



<li>Kulr Technology&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/kulr-stock-quote/">KULR</a>) stock is jumping more than 19% on Tuesday morning.</li>



<li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) shares are up over 15% with no obvious news to report.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Lichen China (NASDAQ:<a href="https://investorplace.com/stock-quotes/licn-stock-quote/">LICN</a>) stock is diving more than 22% following a major rally on Monday.</li>



<li>Medifast (NYSE:<a href="https://investorplace.com/stock-quotes/med-stock-quote/">MED</a>) shares are tumbling over 15% alongside its <a href="https://www.nasdaq.com/press-release/medifast-announces-first-quarter-2024-financial-results-2024-04-29">Q1 earnings report</a>.</li>



<li>iClick Interactive Asia (NASDAQ:<a href="https://investorplace.com/stock-quotes/iclk-stock-quote/">ICLK</a>) stock is taking a more than 15% beating this morning.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) shares are sliding over 14% <a href="https://www.nasdaq.com/press-release/coursera-reports-first-quarter-2024-financial-results-2024-04-29">with a lackluster guidance</a>.</li>



<li>BioSig Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/bsgm-stock-quote/">BSGM</a>) stock is dropping more than 13% without any obvious news this morning.</li>



<li>Intelligent Living (NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) shares are decreasing 13% on Tuesday morning.</li>



<li>Chegg (NYSE:<a href="https://investorplace.com/stock-quotes/chgg-stock-quote/">CHGG</a>) stock is falling over 12% <a href="https://www.marketwatch.com/story/coursera-chegg-stocks-fall-after-weaker-guidance-for-both-edtech-companies-a77adfe2">on weak guidance</a>.</li>



<li>Complete Solaria (NASDAQ:<a href="https://investorplace.com/stock-quotes/cslr-stock-quote/">CSLR</a>) shares are slipping more than 12% after <a href="https://finance.yahoo.com/news/complete-solaria-names-t-j-164700180.html">naming a new CEO</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is dipping almost 12% today.</li>



<li>MediaCo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdia-stock-quote/">MDIA</a>) shares close out our pre-market stock movers down over 11% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318273213&amp;type=PDF&amp;symbol=MDIA&amp;cdn=80615736f767ff769473a389abcd6e9f&amp;companyName=Mediaco+Holding+Inc.&amp;formType=4%2FA&amp;formDescription=%5BAmend%5D+Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-29">on insider trading</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-april-30th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Tuesday morning!



<a href="https://investorplace.com/stock-types/meme-stocks/">Meme stocks</a> continue to rally, companies release earnings reports, and more market news has shares moving today.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>AMC Entertainment (NYSE:<a href="https://investorplace.com/stock-quotes/amc-stock-quote/">AMC</a>) stock is rocketing more than 59% as <a href="https://twitter.com/TheRoaringKitty">Roaring Kitty&rsquo;s return</a> continues to bolster the shares.</li>



<li>GameStop (NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) shares are soaring over 54% alongside the return of Roaring Kitty.</li>



<li>MicroCloud Hologram (NASDAQ:<a href="https://investorplace.com/stock-quotes/holo-stock-quote/">HOLO</a>) stock is surging 41% with heavy pre-market trading.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) shares are gaining more than 34% with strong early morning trading today.</li>



<li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is increasing over 27% without any clear news this morning.</li>



<li>BlackBerry (NYSE:<a href="https://investorplace.com/stock-quotes/bb-stock-quote/">BB</a>) shares are rising more than 24% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318312931&amp;type=PDF&amp;symbol=BB&amp;cdn=4b26c072318efaefdc3ba22b7b5e8deb&amp;companyName=BlackBerry+Limited&amp;formType=DEFA14A&amp;formDescription=Additional+proxy+soliciting+materials+-+definitive&amp;dateFiled=2024-05-13">shareholder meeting update</a>.</li>



<li>Rent the Runway (NASDAQ:<a href="https://investorplace.com/stock-quotes/rent-stock-quote/">RENT</a>) stock is climbing over 19% this morning.</li>



<li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) shares are heading more than 19% higher <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318314743&amp;type=PDF&amp;symbol=SPWR&amp;cdn=ecf4fe81973e2491082785bf9c740edb&amp;companyName=SunPower+Corporation&amp;formType=NT+10-Q&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-Q+or+10-QSB&amp;dateFiled=2024-05-13">despite a delayed filing</a>.</li>



<li>AMTD Digital (NYSE:<a href="https://investorplace.com/stock-quotes/hkd-stock-quote/">HKD</a>) stock is jumping over 18% on Tuesday morning.</li>



<li>Koss (NASDAQ:<a href="https://investorplace.com/stock-quotes/koss-stock-quote/">KOSS</a>) shares are up more than 16% <a href="https://investorplace.com/2024/05/blast-from-the-past-former-meme-koss-stock-soars-on-roaring-kitty-news/">alongside the meme stock rally</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Inotiv (NASDAQ:<a href="https://investorplace.com/stock-quotes/notv-stock-quote/">NOTV</a>) stock is plummeting over 34% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318314218&amp;type=PDF&amp;symbol=NOTV&amp;cdn=ebe87b345e7637122dc6a4d631ded890&amp;companyName=Inotiv+Inc.&amp;formType=NT+10-Q&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-Q+or+10-QSB&amp;dateFiled=2024-05-13">alongside preliminary earnings</a>.</li>



<li>Augmedix (NASDAQ:<a href="https://investorplace.com/stock-quotes/augx-stock-quote/">AUGX</a>) shares are diving close to 33% after releasing its <a href="https://www.nasdaq.com/press-release/augmedix-delivers-40-revenue-growth-for-first-quarter-of-2024-2024-05-13">latest earnings report</a>.</li>



<li>Scorpius (NYSEMKT:<a href="https://investorplace.com/stock-quotes/scpx-stock-quote/">SCPX</a>) stock is tumbling more than 22% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318315844&amp;type=PDF&amp;symbol=SCPX&amp;cdn=2f4148150720f83231bf9f50680f426c&amp;companyName=Scorpius+Holdings+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-05-13">with a public offering</a>.</li>



<li>Akoya Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/akya-stock-quote/">AKYA</a>) shares are taking an over 19% beating after <a href="https://www.marketwatch.com/story/shares-of-akoya-biosciences-drop-after-1q-earnings-revenue-outlook-miss-c9dded98?mod=newsviewer_click">missing Q1 estimates</a>.</li>



<li>Eastside Distilling (NASDAQ:<a href="https://investorplace.com/stock-quotes/east-stock-quote/">EAST</a>) stock is dropping more than 18% after <a href="https://www.nasdaq.com/press-release/eastside-distilling-reports-first-quarter-2024-financial-results-2024-05-13">posting its Q1 results</a>.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) shares are sliding over 14% this morning.</li>



<li>Terran Orbital (NYSE:<a href="https://investorplace.com/stock-quotes/llap-stock-quote/">LLAP</a>) stock is falling more than 14% with its <a href="https://www.businesswire.com/news/home/20240514904938/en/Terran-Orbital-Reports-First-Quarter-2024-Financial-Results">Q1 earnings report</a>.</li>



<li>Hanryu (NASDAQ:<a href="https://investorplace.com/stock-quotes/hryu-stock-quote/">HRYU</a>) shares are slipping over 13% this morning.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is dipping more than 12% today.</li>



<li>Intelligent Living (NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) shares close out our pre-market stock movers down over 12% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-may-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Intelligent Living Application Group Incorporation (ILAG) has released an update. Intelligent Living Application Group Inc., a leading lockset manu...

Intelligent Living Teams Up with AI Robotics Firm

Intelligent Living Application Group Incorporation (ILAG) has released an update. Intelligent Living Application Group Inc. invites shareholders to...

Intelligent Living Group Calls for Share Consolidation Vote

Intelligent Living Application Group Incorporation (ILAG) has released an update. Intelligent Living Application Group Inc., a Hong Kong-based prem...

Intelligent Living Regains Nasdaq Compliance

Intelligent Living Application Group regains Nasdaq compliance

ACRV

AGBA

AKYA

ATGL

AUGX

EAST

FFIE

HOLO

HUGE

INVO

IONM

KOSS

KULR

LLAP

MDIA

NOTV

NUTX

NUWE

NUZE

RENT

SCPX

SPWR

Earnings

Press Releases

Real Estate

Intelligent Living Application Group Inc. Announces First Half 2023 Unaudited Financial Results

Intelligent Living Application Group Inc. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Contracts

Intelligent Living Application Group Inc. Announces Strategic Cooperation with Artificial Intelligence Assisted Robotic Research Firm in Hong Kong

Intelligent Living Application Group Inc. Regains Compliance with Nasdaq's Minimum Bid Price Rule

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Intelligent Living

Intelligent Living (ILAG) Forecast

Intelligent Living (NASDAQ:ILAG) Stock, Quote.Headers.trade-ideas